Nitto Denko Corp. engages in the manufacture and sale of adhesives, optical films, semiconductors, electronic devices, and consumer products. It operates through the following segments: Industrial Tape, Optronics, Human Life, and Others. The Industrial Tape segment deals with the manufacture and sale of sealing, protective, process, and automotive materials. The Optronics segment offers optical films, printed circuits, and high-precision substrates. The Human Life segment handles the manufacturing services for nucleic acids, nucleic acid synthesis materials, and medical-related materials. The Others segment includes new businesses. The company was founded on October 25, 1918 and is headquartered in Osaka, Japan.

SurExam Bio-Tech Co., Ltd. provides personalized medical system solutions focused on tumor molecular diagnostic products and clinical medicine testing services. Its products include medical kits, as well as it provides medical testing services. The company was founded on November 28, 2006 and is headquartered in Guangzhou, China.

Direct Genomics is making genomics an affordable part of everyday patient care. The company’s GenoCare instrument is the first single molecule sequencing system for clinical use. That simplifies sequencing by directly reading individual DNA and RNA molecule information from customer’s blood or tissue samples, delivering significant improvements in cost and speed. Established in 2012, Direct Genomics is headquartered in Shenzhen, China and backed by institutional and private investors.

Beijing ACCB Biotech Ltd. (雅康博生物) is focused on the research and development of cancer detection methods through the application of molecular biology technologies. Based on the concept of personalized therapy, the company provides detection services that include early-cancer screening, drug selection, effect tracking, prognostic evaluation, transfer and recurrence monitoring, and other testing services. ACCB Biotech’s product series include EnzymAct, Baikangan, Gene 21 of Breast Cancer, automated workstation for nucleic acid extraction, and more. The company now has production, research and development, and service facilities of more than 3,000 square meters, and its cleanliness attains the criteria of 10,000 grades. In June, 2009, EnzymAct® was successfully approved by the State Food and Drug Administration.

Manufactures electrical insulation materials and appliances

GENECAST Co. Ltd. engages in the development and sale of cancer diagnosis and testing products. It offers cancer diagnosis pltform and oncology kits The company was founded by Seung-Chan Baek on October 26, 2016 and is headquartered in Seoul, South Korea.

Jiangsu Bojia Biomedical Technology Co., Ltd., established on 2021-04-02, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Veterinary drug production;Quality and safety inspection of agricultural products;Production of Class II Medical Devices;Forestry product quality inspection and testing;Quality inspection of edible fungi;Forest grass seed quality inspection;Crop Seed Quality Inspection;Entry-Exit Quarantine Processing;Import and export commodity inspection and appraisal;Inspection and testing service;Safety production inspection and testing;Indoor environment detection;patent agency;Veterinary drug business;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Production of hygiene products and single-use medical products(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Water Environment Pollution Prevention and Control Services;Atmospheric Environmental Pollution Prevention and Control Services;Agricultural non-point source and heavy metal pollution prevention and control technical services;Indoor Air Pollution Control;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Vector Biodensity Control Level Evaluation Service;Vector Biodensity Monitoring and Evaluation Service;Development of Human Gene Diagnosis and Therapy Technology;R&D of industrial enzyme preparations;Fermentation process optimization technology research and development;Technology intermediary service;New material technology promotion service;New material technology research and development;Vector biological control services;Animal Husbandry Professional and Auxiliary Activities;Sales of air pollution monitoring and testing instruments;Sales of water pollutant monitoring and testing instruments;Manufacturing of ecological environment monitoring and testing instruments;internet sales(Except for products that require a license for sale);Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Experimental analysis instrument sales;Glassware Sales;Retailing of protective equipment for healthcare workers;Cosmetics Wholesale;Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Youshengkang Biotechnology Co., Ltd. (Shenzhen) is a Chinese company located in Shenzhen. The firm engages in research & development, production and marketing of vitro molecular diagnostic products. It was founded in 2015. De Hua Yu is currently the CEO of the company.

Shanghai Rigen Biotechnology Co. Ltd. is a company headquartered in China. The firm provides research and development services.

Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene testing panels, NGS panels, and NGS analytical systems.

Shanghai Sai'an Biomedical Technology Co., Ltd., established on 2010-02-04, Business scope includes biotechnology,Engage in technology development in the field of medical science and technology,technology transfer,Technical Services,technical consulting;Medical Device Sales;Business Consulting. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

CarrierGene Biotech Co., Ltd. engages in the identification of the causes of infertility for patients through genetic testing technology and data analysis algorithms. The company was founded in 2016 and is headquartered in Suzhou, China.

Guangzhou Daan Gene Co., Ltd., established on 1988-08-17, Business scope includes agricultural scientific research and experimental development;Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Medical equipment rental;Development of Human Gene Diagnosis and Therapy Technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;R&D and application of cell technology;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;General machinery and equipment installation services;Special Equipment Repair;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Professional Design Services;software development;Machinery sales;Mechanical Parts,Parts sales;Engage in investment activities with own funds;Engineering Management Services;Refrigeration,Air Conditioning Equipment Manufacturing;General Equipment Repair;Auto New Car Sales;housing lease;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;pharmaceutical production;Inspection and testing service;Residential interior decoration;Import and export;Securities Investment Consulting;Construction Engineering Construction

Wuxi Zhenhe Biotechnology Co., Ltd., established on 2014-11-17, Business scope includes licensed projects:Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Data processing and storage support services;Medical Research and Experimental Development;Retailing of computer software, hardware and auxiliary equipment;Communication equipment wholesale;Retailing of Class I Medical Devices;Wholesale of Class I Medical Devices;Wholesale of chemical products(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precision medicine, striving to help the patients through early, accurate and informative diagnoses.

Beijing Mingdi Biomedical Technology Co. Ltd. is a Chinese private company located in Beijing involved in medicinal chemicals and botanical products.

Wuhan Bojie Biomedical Technology Co., Ltd., established on 2016-02-04, Business scope includes medical software development;Precision diagnosis and treatment technical consultation,technology development,technology transfer,Technical Services;Third-party medical testing;medical service;laboratory reagent(Does not contain dangerous goods),Instrumentation(Without metering),Wholesale and retail of computer software and auxiliary equipment;Cultural and artistic activities exchange planning(Does not include commercial performances);Conference and Exhibition Services;translation service;advertising design,make,acting,release.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China.

Jiangsu Kunyuan Biotechnology Co., Ltd., established on 2020-11-20, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Experimental analysis instrument sales;Manufacturing of experimental analysis instruments;Technology intermediary service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of Genetron Holdings Ltd., Genetron Health (Beijing) Co., Ltd. is a company headquartered in China. The firm manufactures health management products for cancer clinical treatment.